Sustainability
WeCare
Inspired by our purpose to revolutionise care for people and planet, our sustainability roadmap to 2030, WeCare, guides us and lends structure to our sustainability efforts. It is a driver for growth, innovation and productivity and an essential part of our employee value proposition.
We are committed to transforming our business to become a global leader in sustainable healthcare. This transformation entails embedding sustainability into every aspect of our operations, offers, and partnerships.
Creating shared value
True transformation happens when social, environmental and economic dimensions are seamlessly integrated into our business strategy. This holistic approach ensures that our actions generate value across all three areas. By embedding sustainability into everything we do, we aim to improve health and wellbeing for more people today while safeguarding the planet’s resources for future generations.
Collaboration for lasting change
At Mölnlycke, we differentiate ourselves by collaborating across our value chains to deliver lasting benefits for society and the environment. Together, we are committed to eliminating GHG emissions, waste, and harm, and the delivery of positive societal value. Our ambition is to ensure a future where healthcare is not only efficient but truly sustainable.
Read more on how to partner with us
Commitment to global goals
Our corporate goals are aligned with the United Nations Sustainable Development Goals (SDGs) most relevant to Mölnlycke. We are committed to making a measurable, focused contribution to these global objectives, ensuring that our progress benefits both people and the planet.
Revolutionising care
Governance
Ethical business culture
We set high standards of ethics and responsibility in our business and act with integrity and care for human rights throughout our value chain. Mölnlycke is a signatory of the UN Global Compact and is committed to responsible business practices. For details see here.
Transparent reporting for informed sustainable decisions
Transparency in reporting is central to our sustainability efforts. We ensure data is accurate, accessible and actionable for our customers and other stakeholders. By refining how we communicate, we address a core need for clarity, enabling informed, sustainable choices across the healthcare sector.
-
Double Materiality Assessment (DMA)
In 2024, we conducted a Double Materiality Assessent (DMA) to enhance our understanding of material sustainability-related impacts, risks and opportunities, in alignment with CSRD requirements for identifying and evaluating ESG-related factors. The validated DMA will inform Mölnlycke’s sustainability roadmap and disclosures. The results of the DMA are presented in the table below.
The scope of the assessment included all operations of Mölnlycke, including subsidiaries and joint ventures, as well as its upstream and downstream value chain, and was global in geographic scope.
"Recognising the profound and ongoing pressure on environment, society and global healthcare systems in particular, Mölnlycke are accelerating our transformation to deliver sustainable healthcare solutions. We are uniquely positioned to improve patient lives while reducing the environmental impact of healthcare."
Zlatko Rihter Chief Executive Officer
Our commitment to reach Net Zero by 2050
We've formalised our climate change mitigation efforts by publicly committing to the Science Based Targets Initiative (SBTi), and securing their validation of our near-term climate targets, detailed below:
-
Reducing absolute scope 1 and 2 Greenhouse gas (GHG) emissions
Reducing absolute scope 1 and 2 GHG emissions by 50% by 2030 from a 2021 base year.
-
Increasing active annual sourcing of renewable electricity
Increasing active annual sourcing of renewable electricity from 23% in 2021 to 100% by the end of 2024 and continuing active annual sourcing of 100% of renewable electricity through 2030.
-
Reducing absolute scope 3 GHG emissions
Reducing absolute scope 3 GHG emissions from purchased goods and services (cat. 1), fuel and energy related activity (cat. 3), upstream transportation and distribution (cat. 4) and waste generated in operations (cat. 5) by 20% by 2028 from a 2021 base year.
-
Supplier engagement
Having 63% of our suppliers by emissions covering purchased goods and services (cat. 1) capital goods (cat. 2), and upstream transportation and distribution (cat. 4) committed to the Science Based Targets Initiative by 2028.
Milestones on the way to Net Zero
2016: Scope 1 and 2 GHG emissions measured and baseline established.
2021: Materiality analysis and development of WeCare (2030 sustainability roadmap).
2021: Upstream and downstream scope 3 GHG emissions measured and baseline established.
2021: First range of BARRIER® surgical drapes launched with demonstrable reductions in emissions.
2022: Commitment to SBTi and nine manufacturing sites operating on 100% fossil-free electricity.
2023: Validation of near-term GHG emission reduction targets by SBTi.
2023: Sustainable Product Portfolio Assessment conduced for Operation Room Solutions and Antiseptics portfolios.
2024: 100% renewable electricity at all manufacturing sites and the headqarters
Sustainability news
See all news-
Mölnlycke Health Care wins Swedish Sustainability Tech award
Mölnlycke is proud to announce that it has been awarded the Capgemini Swedish Sustainability Tech Award 2024 for Mölnlycke ProcedurePak® trays. This accolade recognises the company’s innovative practices and dedication to revolutionise healthcare for people and planet.
-
Mölnlycke Health Care and Operation Smile help to change people's lives with newly inaugurated cleft care centre in Philippines
The centre is expected to serve 10,000 patients in the region with transformative cleft care in the first three years of operations.
-
Mölnlycke sets sail with ocean biofuel: A step towards greener logistics
-
Mölnlycke to help establish cleft care centre in the Philippines
World-leading medical solutions company Mölnlycke is setting up a centre for cleft care in the Philippine city of Cebu with its long-term charity partner Operation Smile.
-
In 2023 Mölnlycke was awarded a gold medal for Sustainability by EcoVadis
The world’s largest and most trusted provider of business sustainability ratings - EcoVadis, has awarded Mölnlycke a gold medal for our focus on sustainability. They have ranked us in the top 3% of companies worldwide.
-
Mölnlycke awarded a Platinum medal from EcoVadis in 2024
-
Mölnlycke integrated Annual Report 2023
Today we are delighted to announce the launch of the Mölnlycke integrated Annual Report 2023. Our dedication to revolutionising care for people and planet contributed to a very successful year with record high annual net sales of EUR 1,924 million and substantial improvements in profitability. We continue to report our sustainability achievements in accordance with the Global Reporting Initiative (GRI) standards.
-
Mölnlycke Health Care reaches 100% renewable electricity target
Mölnlycke, a world leading MedTech company, has secured 100% renewable electricity for all its established and new manufacturing sites and its headquarters, reaching its first near-term SBTi (Science Based Targets initiative)-validated target.